Real-World Evidence for Decisions in Diabetes

VISION

RESEARCH

NETWORK

ABOUT REDDIE

Randomised controlled trials (RCT) are the cornerstone of evidence-based medicine. However, the digitisation of real-world data (RWD) including data from devices, wearables, and electronic health records in large national registries provides opportunities to demonstrate efficacy and safety of innovative technologies including drugs, devices, diagnostics, and digital health. These data are particularly relevant to long-term conditions such as diabetes mellitus, where drugs, lifestyle interventions, and digital technologies often work together.

Learn more

“In REDDIE, we will first define a typical target parameter of an RCT and then look for all people exposed to the same intervention in four comprehensive European real-world databases (Sweden, Denmark, Germany and England).

In this way, we ‘recreate’ the RCT trial within the real-world databases. Due to the large amount of real-world data we have available, we will get much faster answers to our research questions, tested in a much bigger cohort than this would ever be possible with RCTs.”

Dr Julia Mader, Medical University of Graz, REDDIE coordinator

Quote author

KEY FACTS

01 JAN 2023
START DATE
4 Years
DURATION
4,78 Mil €
BUDGET
14 Partners
FROM 7 COUNTRIES

NEWS

Diabetes UK Professional Conference 2024

The Diabetes UK Professional Conference 2024 starts tomorrow. Organised by the Diabetes UK organisation, it will take place at the ExCeL London from 1...

3rd Advances in Hypoglycaemia Scientific Conference

The 3rd Advances in Hypoglycaemia Scientific Conference organised by IHSG kicks off today.

From April 8-12, experts will have the opportunity to con...

World Physical Activity Day

As April 6th marks World Physical Activity Day, it's an opportunity to debunk some common myths about diabetes. One prevalent misconception is the bel...

EU Lawmakers Reach Agreement on AI Act

After months of intensive negotiations, European Union legislators have reached a political agreement on the artificial intelligence (AI) act.

The d...

The 17th International ATTD Conference

Today kicks off the first day of the 17th International Conference on Advanced Technologies and Treatments for Diabetes in Florence, Italy.

A few RE...

Artificial Intelligence Methods to Power Real-World Clinical Studies

On February 23rd, our partners from UNIPD presented the REDDIE project at the research event "DEI-AI 2024" organised by the Dept. of Information Engineering, UniPD.

REDDIE at The Evidence Base

Interview with Julia Mader and Martina Radanović: REDDIE project featured in The Evidence Based magazine

REDDIE General Assembly meeting

On December 7th, the REDDIE consortium gathered virtually for their first General Assembly meeting. Approximately 30 consortium members participated...

DIA Innovating Clinical Trials in Europe Conference

On November 15th, Martina Radanović, REDDIE’s Project Manager from EURICE, showcased the project at the "DIA Innovating Clinical Trials in Europe Virt...

MetReal Cluster meeting

On October 30, the MetReal cluster gathered all the representatives from sister projects. Representatives from Real4Reg, ONOVACULATE, REALM, More-Euro...

First REDDIE Stakeholder Meeting

Hamburg/Germany, 1 October 2023

REDDIE (Real-World Evidence for Decisions in Diabetes) aims to explore how real-world evidence can complement rand...

Save the date: REDDIE Stakeholder meeting

The REDDIE project is delighted to announce its upcoming face-to-face stakeholder meeting, scheduled for October 1st 2023 in Hamburg, Germany. The mee...

LTMLE Workshop held in Copenhagen

On the 22nd and 23rd May 2023, the “LTMLE Workshop” organised by the REDDIE work package 4 took place in Copenhagen, Denmark. Kindly hosted by the University of Copenhagen

New Project “REDDIE”

New EU Research Project REDDIE Investigates Use of Real-World Data to Improve Health Technology Assessments and Regulatory Guidance for Diabetes Care...